CLEARMIND MEDICINE INC (CMND)
Institutional ownership reported to the SEC as of Q1 2026, across 14 quarters.
Institutions report 44,962 shares against 158,076 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. Share count carried from an earlier filing (cy2025q4i).
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| XTX Topco Ltd | $22.6K | 21,694 | 0.00% | new | NEW |
| AdvisorShares Investments LLC | $7.7K | 7,357 | 0.00% | 2q | +10.9% |
| HRT FINANCIAL LP | $16 | 15,910 | 0.00% | new | NEW |
| UBS Group AG | $1 | 1 | 0.00% | new | NEW |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-12 | 13G/A | Iroquois Capital Management, LLCwith 2 co-filers | 10.0% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 4 | $30.2K | 44,962 | 3 | 1 | 0 | 0.0% |
| Q4 2025 | 2 | $12.0K | 6,637 | 2 | 0 | 0 | 0.0% |
| Q3 2025 | 6 | $259.3K | 252,577 | 1 | 1 | 1 | 0.0% |
| Q2 2025 | 8 | $218.1K | 245,468 | 3 | 1 | 1 | 0.0% |
| Q1 2025 | 6 | $266.7K | 258,348 | 1 | 1 | 0 | 0.0% |
| Q4 2024 | 7 | $318.2K | 230,461 | 2 | 1 | 1 | 0.0% |
| Q3 2024 | 6 | $428.1K | 350,655 | 3 | 1 | 0 | 0.0% |
| Q2 2024 | 4 | $276.0K | 165,796 | 1 | 2 | 0 | 0.0% |
| Q1 2024 | 4 | $175.3K | 153,477 | 3 | 1 | 0 | 0.0% |
| Q4 2023 | 1 | $260.5K | 92,693 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 6 | $137.1K | 857,005 | 3 | 1 | 1 | 0.0% |
| Q2 2023 | 6 | $107.4K | 228,344 | 2 | 2 | 2 | 0.0% |
| Q1 2023 | 4 | $251.1K | 218,365 | 3 | 1 | 0 | 0.0% |
| Q4 2022 | 3 | $148.2K | 46,909 | 3 | 0 | 0 | 0.0% |